MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$3,098,366
Accounts and other
receivables, net
$685,235
Prepaid expenses and
other current assets
$479,913
Inventory
$77,887
Property and equipment,
gross
$952,831
Total current assets
$4,341,401
Goodwill
$1,404,486
Intangible assets, net
$702,222
Operating lease
right-of-use asset, net
$651,430
Finance lease
right-of-use asset, net
$586,048
Property and equipment,
net
$246,849
Other assets
$12,816
Less accumulated
depreciation and...
$705,982
Total assets
$7,945,252
Total liabilities,
and stockholders...
$7,945,252
Total liabilities
$4,283,866
Total stockholders
equity
$3,661,386
Accumulated deficit
-$72,184,674
Total current
liabilities
$3,184,960
Operating lease
liability, net of current...
$545,157
Finance lease
liability, net of current...
$514,834
Notes payable, net of
current portion
$38,915
Additional paid-in capital
$75,814,595
Common stock, par value
0.007 per share...
$31,464
Preferred stock, par value
0.001 per share...
$1
Accrued expenses
$2,033,924
Accounts payable
$836,211
Operating lease
liability, current portion
$142,303
Finance lease
liability, current portion
$80,241
Notes payable,
current portion
$61,141
Unearned revenue
$31,140
Back
Back
Balance Sheet
bioAffinity Technologies, Inc. (BIAFW)
bioAffinity Technologies, Inc. (BIAFW)
source: myfinsight.com